Page 2 - Robertg Burrows News Today

GAITHERSBURG, Md., April 08, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 28, 2022, at...

EBS earnings call for the period ending October 3, 2021.

Emergent BioSolutions Inc (EBS) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Emergent BioSolutions Inc (NYSE: EBS) Popular Searches Operator Thank you for standing by, and welcome to the Emergent BioSolutions First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to Bob Burrows. Please go ahead.SPONSORED: 10 stocks we like better than Emergent B...

About Emergent BioSolutions Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on whats most important in their lives. In wor...

Home / Top News / Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments; Receives Modified Task Order from the U.S. Department of Health & Human Services to Support the Opportunity for Further Expansion of Manufacturing Capacity for Johnson & Johnson’s COVID-19 Vaccine Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments; Receives Modified Task Order from the U.S. Department of Health & Human Services to Support the Opportunity for Further ...

Government purchases for the Strategic National Stockpile, the country’s emergency medical reserve, have largely been driven by the demands and interests of a handful of biotech firms.

Government purchases for the Strategic National Stockpile, the country’s emergency medical reserve, have largely been driven by the demands and interests of a handful of biotech firms.

A year ago, President Donald J. Trump declared a national emergency, promising a wartime footing to combat the coronavirus.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical ... Emergent BioSolutionsDecember 29, 2020 GMT GAITHERSBURG, Md. and NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) and Mount Sinai Health System today announced initiation of the clinical program to evaluate Emergent’s COVID-19 Human Hyperimmune Globulin (COVID-HIG) product ...

Home / Top News / Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis GAITHERSBURG, Md. and NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) — Emergent BioSolution...